|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 31 |
Q
V+
PT
|
10,387 Small Cap |
1,121.50 (-0.48%) |
56.56 | 3.16 | 4.81 | -16.98 |
|
|
| 32 |
Q
V
PT
|
40,535 Mid Cap |
2,400.60 (0.33%) |
39.13 | 17.75 | 5.49 | 17.52 |
|
|
| 33 |
Q
V+
PT
|
20,645 Small Cap |
854.40 (2.55%) |
51.53 | 4.69 | 5.58 | -0.56 |
|
|
| 34 |
Q
V
PT
|
12,853 Small Cap |
289.40 (-1.63%) |
72.5 | 4.42 | 5.64 | -18.41 |
|
|
| 35 |
Q
V+
PT
|
66,606 Mid Cap |
5,597.50 (0.48%) |
30.48 | 4.76 | 5.71 | 10.33 |
|
|
| 36 |
Q
V+
PT
|
3,522 Small Cap |
379.55 (-1.63%) |
18.07 | 2.27 | 5.74 | 4.42 |
|
|
| 37 |
Q
V
PT
|
1,161 Small Cap |
335.40 (-2.71%) |
54.46 | 2.18 | 5.76 | 2.91 |
|
|
| 38 |
Q
V+
PT
|
3,082 Small Cap |
195.80 (-0.41%) |
31.63 | 0.46 | 5.82 | -33.01 |
|
|
| 39 |
Q
V+
PT
|
2,257 Small Cap |
235.95 (-3.52%) |
N/A | 2.05 | 6.54 | -182.78 |
|
|
| 40 |
Q
V
PT
|
1,879 Small Cap |
2,163.15 (-2.07%) |
36.07 | 4.88 | 6.98 | 0.80 |
|
|
| 41 |
Q
V+
PT
|
83,293 Mid Cap |
1,529.20 (-0.81%) |
93.72 | 15.79 | 7.19 | -2.25 |
|
|
| 42 |
Q
V+
PT
|
11,902 Small Cap |
595.65 (-2.12%) |
48.91 | 4.59 | 7.22 | -12.54 |
|
|
| 43 |
Q
V
PT
|
3,564 Small Cap |
322.80 (1.43%) |
27.04 | 5.02 | 7.28 | 11.87 |
|
|
| 44 |
Q
V
PT
|
1,018 Small Cap |
395 (14.21%) |
15.83 | 2.41 | 7.46 | 0.93 |
|
|
| 45 |
Q
V+
PT
|
17,401 Small Cap |
452.80 (-0.45%) |
97.09 | 4.45 | 7.51 | -3.15 |
|
|
| 46 |
Q
V+
PT
|
16,169 Small Cap |
834.45 (1.44%) |
23.96 | 2.85 | 7.69 | -8.97 |
|
|
| 47 |
Q
V
PT
|
1,17,820 Mid Cap |
1,471.25 (0.88%) |
30.37 | 3.43 | 8.01 | 10.07 |
|
|
| 48 |
Q
V
PT
|
1,13,215 Mid Cap |
2,492.45 (0.66%) |
21.23 | 5.04 | 8.11 | 0.00 |
|
|
| 49 |
Q
V
PT
|
939 Small Cap |
192.90 (-0.85%) |
30.9 | 2.1 | 8.61 | 14.34 |
|
|
| 50 |
Q
V+
PT
|
45,182 Mid Cap |
1,780.35 (-0.03%) |
39.9 | 5.66 | 8.87 | 4.68 |
|
|
| 51 |
Q
V
PT
|
14,200 Small Cap |
1,149.85 (-0.61%) |
25.16 | 4.26 | 9.20 | 6.61 |
|
|
| 52 |
Q
V
PT
|
11,521 Small Cap |
573.15 (3.14%) |
60.63 | 7.61 | 9.22 | 2.10 |
|
|
| 53 |
Q
V
PT
|
7,054 Small Cap |
429.95 (-0.76%) |
24.67 | 2.83 | 9.23 | 1.32 |
|
|
| 54 |
Q
V
PT
|
40,588 Small Cap |
2,462.45 (0.08%) |
31.23 | 3.75 | 9.35 | 7.37 |
|
|
| 55 |
Q
V
PT
|
54,930 Mid Cap |
26,851.80 (3.87%) |
35.39 | 11.51 | 9.38 | 18.78 |
|
|
| 56 |
Q
V+
PT
|
5,368 Small Cap |
488.65 (-3.46%) |
55.41 | 4.69 | 9.41 | 4.67 |
|
|
| 57 |
Q
V+
PT
|
17,772 Small Cap |
430.50 (-2.21%) |
58.29 | 3.81 | 9.45 | 1.26 |
|
|
| 58 |
Q
V
PT
|
1,425 Small Cap |
270.85 (-1.01%) |
44.27 | 5.82 | 9.86 | -51.00 |
|
|
| 59 |
Q
V+
PT
|
4,56,989 Large Cap |
1,913.05 (0.44%) |
39.81 | 5.47 | 9.87 | 23.50 |
|
|
| 60 |
Q
V
PT
|
9,856 Small Cap |
624.30 (-0.30%) |
88.28 | 4.06 | 10.00 | 11.58 |
|
|
Pharma - Today's Top Gainers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 395 | 14.21% | |
| 293.10 | 10.42% | |
| 261.65 | 9.41% | |
| 276.30 | 6.11% | |
| 1,362.85 | 4.61% |
Pharma - Today's Top Losers
| Company Name | CMP | Price Change(%) |
|---|---|---|
| 865.75 | -11.62% | |
| 3,514.30 | -4.78% | |
| 375.05 | -4.08% | |
| 314.90 | -3.86% | |
| 37.87 | -3.66% |
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Jubilant Pharmova Ltd. | 15,430 Crore |
| 2 | Suven Life Sciences Ltd. | 8,647 Crore |
| 3 | Aster DM Healthcare Ltd. | 41,071 Crore |
| 4 | Panacea Biotec Ltd. | 3,366 Crore |
| 5 | Sanofi India Ltd. | 7,890 Crore |
| 6 | Nectar Lifesciences Ltd. | 230 Crore |
| 7 | Novartis India Ltd. | 3,627 Crore |
| 8 | Aurobindo Pharma Ltd. | 93,217 Crore |
| 9 | Apollo Hospitals Enterprise Ltd. | 1,27,930 Crore |
| 10 | Sun Pharma Advanced Research Company Ltd. | 7,761 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 26,852 | 54,930 | 35.39 | 11.51 | 24.16 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,823 | 1,61,290 | 74.55 | 19.23 | 39.18 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,371 | 41,550 | 39.35 | 9.18 | 26.59 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,492 | 1,13,215 | 21.23 | 5.04 | 12.28 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,148 | 1,13,815 | 22.58 | 4.38 | 13.82 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,529 | 83,293 | 103 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,391 | 37,944 | 44.17 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,823 | 1,61,290 | 42.84 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,594 | 93,217 | 40.20 |
| Gland Pharma Ltd. (S) | Very Good | 2,462 | 40,588 | 31.30 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,391 | 37,944 | 56.29 | 9.40 | 34.09 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,540 | 1,04,535 | 51.30 | 6.38 | 32.20 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,371 | 41,550 | 39.35 | 9.18 | 26.59 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,369 | 1,14,730 | 27.34 | 3.04 | 15.25 | 12.09 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,823 | 1,61,290 | 74.55 | 19.23 | 39.18 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,148 | 1,13,815 | 22.58 | 4.38 | 13.82 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,913 | 4,56,989 | 39.81 | 5.47 | 22.81 | 23.50 |
| Abbott India Ltd. (M) | Very Good | 26,852 | 54,930 | 35.39 | 11.51 | 24.16 | 18.78 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,369 | 1,14,730 | 27.34 | 3.04 | 15.25 | 15.75 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,270 | 62,362 | 45.79 | 5.93 | 12.16 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: